v v v
PRESCRIBERS 1ST EDITION BY LUO K
v v v v v
AYINGO TEST BANK | 2024 UPDATE
v v v v v
, Table of Contents
v v
Chapterv 1:vAnvIntroductionvtovEvidence-BasedvClinicalv PracticevGuidelines .............................................. 3
Chapterv 2:vPharmacokineticsv /Chapter3:vPharmacodynamics .................................................................... 13
Chapter4:vPharmacogeneticsv andvPharmacogenomics ................................................................................ 25
Chapterv 5:vPharmacologyv Acrossv thevLifevSpan ......................................................................................... 30
Chapterv 6:vDrug-TherapyvPrescribingvinvSpecialvPopulations .................................................................... 36
Chapterv 7:vDrugvDevelopmentv andvApproval ............................................................................................. 45
Chapterv 8-Chapterv 10:vFoundationsv ofvPrescriptionvWritingvChapterv 9:vResponsibleControlled-
SubstancevPrescribingvChapterv10:vAntibioticvStewardship ........................................................................ 51
Chapterv 11:vAppliedvCalculationsv forv Prescribing ...................................................................................... 58
Chapterv 12-:vPromotingv AdherencevWithvPharmacotherapyv II:vSystem-SpecificvandvPatient-
FocusedvPrescribingvChapterv 13:vPharmacotherapyvforv Ear,v Nose,v Mouth,v andThroatvConditionsv/Chapterv
14:vPharmacotherapyvforvEyevConditions .................................................................................................... 67
Chapterv 15:vPharmacotherapyvforv Skinv Conditions .................................................................................... 74
Chapterv 16:vPharmacotherapyv forv Neurologicv Conditions .......................................................................... 81
Chapterv 17:vPharmacotherapyvforv Cardiovascularv Conditions ................................................................... 94
Chapterv 18:vPharmacotherapyvforv RespiratoryvConditions ....................................................................... 106
Chapterv 19:v Pharmacotherapyv forv Gastrointestinalv Conditionsv andvConditionsv RequiringNutritionalvSuppo
rt ................................................................................................................................................................ 117
Chapterv 20:vPharmacotherapyv forv GenitourinaryvConditions ................................................................... 128
Chapterv 21:vPharmacotherapyvforv Renal,vAcid–Base,v Fluid,vandvElectrolytevDisorders .......................... 133
Chapterv 22:vPharmacotherapyv forv MusculoskeletalvandvRheumatologicv Conditions ............................... 146
Chapterv 23:vTherapeuticv Applicationsv ofv Immunologyvandv Vaccines ...................................................... 158
Chapterv 24:vPharmacotherapyv forv EndocrinevDisorders ........................................................................... 163
Chapterv 25:vPharmacotherapyvforvHematologicv Disorders ....................................................................... 174
Chapterv 26:vHematology/OncologyvandvSupportivevCarevforv thevNononcologist..................................... 190
Chapterv 27:vPharmacotherapyv RelatedvtovWomen’svHealthv Conditions ................................................... 196
Chapterv 28:vPharmacotherapyvRelatedvtovMen’sv Healthv Conditions ........................................................ 211
Chapterv 29:vPharmacotherapyv Relatedv tovTransgenderv Care .................................................................... 217
Chapterv 30:vAntimicrobialvPharmacotherapy............................................................................................ 224
Chapterv 31:vAntiretroviralvPharmacotherapy ............................................................................................ 235
Chapterv32:vPsychopharmacologyvandvIntegrativevHealth:vCombinedvTreatmentvofPsychiatricvandvNeuroco
gnitivevConditions ..................................................................................................................................... 247
Chapterv 33:vPharmacotherapyvforv PainvManagement ............................................................................... 257
Chapterv 34:vSubstancevUsevDisorderv III:v HealthvPromotionvandvMaintenance ......................................... 267
Chapterv 35:vOver-the-Counterv Medications .............................................................................................. 283
Chapterv 36:vPharmacotherapyvforv Obesity ................................................................................................ 291
,Chapterv1:vAnvIntroductionv tovEvidence-Basedv ClinicalvPracticevGuidelines
MULTIPLEvCHOICE
• Whatvisvthevprimaryvpurposevofvthev nursingv assessment?
A. Identifyingv underlyingv pathologicv conditions
B. Assistingv thevphysicianv invidentifyingv medicalv conditions
C. Determiningv thevpatientsvmentalvstatus
D. Exploringv patientv responsesvtov healthv problems
ANS:vD
Avnursingvassessmentv isvdonevtovidentifyvthevpatientsv responsevtovhealthvpro
blems.vDuringvthevnursingv assessmentvphase,vavcomprehensivevinformationv
basev isv developedvthroughvavphysicalvexamination,v nursingvhistory,vmedicat
ionvhistory,vandvprofessionalvobservation.vIdentifyingvunderlyingv pathologic
v conditionsv andv assistingv thev physicianv inv identifyingvmedicalvconditionsv isv
notvpartvofvthev nursingvprocess.v Determiningvthevpatientsv mentalvstatusv isv on
ev partv ofvthev nursingv assessment,v butv itv isv notvthevprimaryvpurpose.
DIF:vCognitivev Level:v Comprehensionv
REF:vdmv 36vOBJ:v1v |v3vTOP:vNursingvP
rocessvStep:vAssessment
MSC:vNCLEXv ClientvNeedsv Category:v HealthvPromotionvandv Maintenance
• Whatvisvthevbasisv ofvthevNANDAvIv taxonomy?
A. Functionalv healthvpatterns
B. Humanvresponsevpatterns
C. Basicv humanv needs
D. Pathophysiologicv needs
ANS:vB
ThevNANDAvIvtaxonomyv identifiesv humanv responsev patterns.vFunctiona
lvcomponentsvofvhealthvpatternsvarevlimitedvtovactivity,vfluidvvolume,vnutriti
on,vselfvcare,vandvsensoryvperception.vBasicvhumanvneedsvcomprisevlessvtha
nvmerelyvhealthvpatterns.v Pathophysiologicvneedsv arevnotvpartvofvthevscop
evofvNANDAvI.
, DIF:vCognitivev Level:vKnowledgev
REF:vpp.v37-38vOBJ:v5vTOP:
NursingvProcessvStep:vDiagnosis
MSC:vNCLEXv Clientv Needsv Category:vPhysiologicalv Integrity
• Whichvtaskvisvincludedv invthevassessmentvstepv ofvthev nursingv process?
A. Establishingv patientv goals/outcomes
B. Implementingv thev nursingv carev planv (NCP)
C. Measuringv goal/outcomev achievement
D. Collectingv andv communicatingv data
ANS:vD
Datav arevcollectedvandvcommunicatedv invthevassessmentv phasev ofvthevnursin
gvprocess.vEstablishingv goalsv isvthevfunctionvofvplanning.
Implementingv thevNCPvisv thev functionvofvimplementation.v Measuringvoutco
mevachievementv isvthevfunctionvofvevaluation.
DIF:v Cognitivev Level:v Comprehensionv
REF:vdmv 36vOBJ:v2v |v3vTOP:vNursingvP
rocessvStep:vAssessment
MSC:vNCLEXv ClientvNeedsv Category:v HealthvPromotionvandv Maintenance
• Whichvstatementv regardingv nursingv diagnosesv isv accurate?
a. Nursingvdiagnosesvremainvthevsamev forvasv longvasvthevdiseasev isv present.
b. Nursingv diagnosesv arevwrittenvtovidentifyvdiseasevstates.
c. Nursingv diagnosesvdescribev patientvproblemsv thatv nursesv treat.
d. Nursingvdiagnosesv identifyvcausesv relatedv tovillness.
ANS:vC
Diagnosticv statementsv identifyvproblemsv av nursev isv independentlyvablev tovtr
eatvwithinvthevscopev ofvprofessionalvpractice.vNursingvdiagnosesv varyvwithvt
hevchangingv conditionvofvthevpatient.vThevresponsevpatternsv arevuniquevtovth
evpatientvandvarevnotvdiseasevspecific.vNursingv diagnosesvdescribevthevpatien
tsvhumanvresponsevpattern.
DIF:v Cognitivev Level:v Comprehension